By
Jonathan G.Marquess,PharmD,CDE,CDM
President
The Institute for Wellness and Education
Atlanta,GA
Bryan Bray,PharmD,CPP
Clinical Associate Professor
Greensboro Medical Associates
High Point,NC
Medha Munshi,MD
Beth Israel Deaconess
Medical Center/Harvard Medical
Boston,MA
Faculty Disclosure
Jonathan G. Marquess, PharmD, CDE, CDM: Consultant,Novo
Nordisk,sanofi-aventis,Abbott Diabetes Care;Speaker with
honorarium:Novo Nordisk Inc,sanofi-aventis,Abbott Diabetes Care.
Bryan Bray, PharmD, CPP: Speakers Bureau:Pfizer,sanofi-aventis;
Speaker with honorarium:NovoNordisk Inc.
Medha Munshi, MD: Speaker with honorarium:Novo Nordisk Inc;
Consultant:Takeda.
Goals and Objectives
After completing this continuing education program, the reader should be able to:
- Describe the impact of diabetes on the elderly
population and the risks to patients associated
with poor glycemic control
- List and address specific issues related to the
“geriatric syndrome”that may impact diabetes
disease management
- Identify and address issues specific to elderly
patients with diabetes,including goal setting,
prevention of hypoglycemia,and product and
device selection
- Make recommendations on the addition and
dosing of insulin to treatment regimens and the
appropriate continuance or discontinuance of
oral medications
|